HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of two phenotypically distinct lattice corneal dystrophies caused by mutations in the transforming growth factor beta induced (TGFBI) gene.

AbstractPURPOSE:
In this study, we investigated whether the phenotypic difference observed between two lattice corneal dystrophy type 1 (LCD type 1) cases caused by either a single A546D substitution or an A546D/P551Q double substitution in TGFBIp (transforming growth factor beta induced protein) can be ascribed to (i) a difference in the proteomes of corneal amyloid deposits, (ii) altered proteolysis of TGFBIp, or (iii) structural changes of TGFBIp introduced by the P551Q amino acid substitution.
EXPERIMENTAL DESIGN:
Amyloid deposits were isolated from the corneas of two siblings with LCD type 1 resulting from A546D/P551Q mutations in the TGFBI gene using laser capture microdissection and subsequently analyzed by LC-MS/MS. Proteolytic processing of TGFBIp was addressed by counting peptide spectra. Lastly, to study the possible effect of the P551Q substitution, recombinant FAS1-4 domain variants were subjected to in vitro stability assays.
RESULTS:
The amyloid proteomes and TGFBIp processing of the two A546D/P551Q LCD type 1 cases were similar to each other as well as to the A546D amyloid proteome previously reported by us. The stability assays revealed a minor destabilization of the FAS1-4 domain upon the addition of the P551Q mutation, moreover, it resulted in different accessibility to tryptic cleavage sites between the A546D and A546D/P551Q mutant FAS1-4 domain variants.
CONCLUSION AND CLINICAL RELEVANCE:
The difference in A546D and A546D/P551Q LCD type 1 phenotypes cannot be ascribed to altered corneal amyloid composition or altered in vivo proteolytic processing of TGFBIp. Instead, a small difference in thermodynamic stability introduced by the P551Q mutation most likely causes structural changes of TGFBIp. The MS proteomics data have been deposited to the ProteomeXchange with identifier PXD000307 (http://proteomecentral.proteomexchange.org/dataset/PXD000307).
AuthorsEbbe Toftgaard Poulsen, Kasper Runager, Michael W Risør, Thomas F Dyrlund, Carsten Scavenius, Henrik Karring, Jeppe Praetorius, Henrik Vorum, Daniel E Otzen, Gordon K Klintworth, Jan J Enghild
JournalProteomics. Clinical applications (Proteomics Clin Appl) Vol. 8 Issue 3-4 Pg. 168-77 (Apr 2014) ISSN: 1862-8354 [Electronic] Germany
PMID24302499 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Amyloid
  • Extracellular Matrix Proteins
  • Transforming Growth Factor beta
  • betaIG-H3 protein
Topics
  • Amino Acid Substitution (genetics)
  • Amyloid (metabolism)
  • Chromatography, Liquid
  • Cornea (metabolism, pathology)
  • Corneal Dystrophies, Hereditary (genetics, metabolism, pathology)
  • Extracellular Matrix Proteins (biosynthesis, chemistry, genetics)
  • Humans
  • Laser Capture Microdissection
  • Mutation
  • Proteolysis
  • Tandem Mass Spectrometry
  • Transforming Growth Factor beta (chemistry, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: